Godrej Agrovet Peer Comparison
NSE: GODREJAGRO | BSE: 540743
₹670.05
As on 23-Sep-2026IST
Market cap
₹12,860 Cr
Revenue (TTM)
₹10,474 Cr
P/E Ratio
28.8
P/B Ratio
6
Div. Yield
1.6 %
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
12,860 | 573 | 101 | 59 | 39 |
Revenue (₹ Cr) |
10,474 | 1,718 | 90 | 213 | 1 |
Net Profit (₹ Cr) |
384.15 | 46.43 | 3.59 | 4.66 | -0.40 |
Net Margin (%) |
3.63 | 2.68 | 3.96 | 2.18 | -40.89 |
RoE (%) |
24.56 | 13.15 | 6.13 | 5.10 | -- |
Price to Earnings |
28.78 | 12.35 | 28.23 | 12.75 | -- |
Price-To-Book |
6.02 | 1.64 | 1.69 | 0.64 | 1.70 |
Income Statement (₹ Cr)
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Operating Revenue
|
10,473.61 | 1,718.16 | 89.58 | 212.73 | 0.85 |
|
Total Income
|
10,582.34 | 1,732.44 | 90.80 | 213.79 | 0.97 |
|
Total Expenditure
|
9,639.56 | 1,658.60 | 84.97 | 203.49 | 1.24 |
|
EBITDA
|
834.05 | 59.55 | 4.60 | 9.24 | -0.39 |
|
Depreciation
|
227.64 | 8.30 | 0.22 | 2.68 | 0.00 |
|
EBIT
|
606.41 | 51.26 | 4.38 | 6.56 | -0.39 |
|
Interest
|
132.57 | 2.62 | 0.75 | 1.02 | 0.00 |
|
Other Income
|
108.73 | 14.29 | 1.23 | 1.06 | 0.12 |
|
Exceptional Items
|
-30.44 | 0.47 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
552.13 | 63.40 | 4.85 | 6.60 | -0.28 |
|
Provision for Tax
|
167.98 | 16.97 | 1.26 | 1.94 | 0.12 |
|
Profit after Tax
|
384.15 | 46.43 | 3.59 | 4.66 | -0.40 |
Liabilities (₹ Cr)
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,032.08 | 349.50 | 59.34 | 91.62 | 15.41 |
|
Minority Interest
|
22.10 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
1,077.70 | 23.95 | 1.02 | 1.71 | 0.00 |
|
Current Liabilities
|
2,928.83 | 41.53 | 11.90 | 31.57 | 0.20 |
|
Total Liabilities
|
6,160.85 | 414.98 | 72.25 | 120.37 | 15.61 |
Assets (₹ Cr)
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2,894.61 | 62.88 | 11.15 | 32.71 | 0.15 |
|
Current Assets
|
2,758.50 | 349.72 | 60.54 | 74.47 | 15.46 |
|
Total Assets
|
6,160.85 | 414.98 | 72.25 | 120.37 | 15.61 |
|
Total Debt*
|
1,468.43 | 24.87 | 10.10 | 17.76 | 0.00 |
|
Net Current Assets
|
-170.33 | 308.19 | 48.64 | 42.90 | 15.26 |
|
Contingent Liabilities
|
164.76 | 1.86 | 0.05 | -- | -- |
Cashflow (₹ Cr)
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,281.17 | 53.52 | -1.30 | -5.73 | 0.00 |
|
Cash Flow from Investing Activities
|
-150.39 | -8.92 | -2.95 | -15.77 | -- |
|
Cash from Financing Activities
|
-868.90 | -33.22 | -0.18 | 15.09 | 0.00 |
|
Net Cash Inflow / Outflow
|
261.88 | 11.38 | -4.43 | -6.41 | 0.00 |
Ratios
Profitability Ratios
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
ROCE (%)
|
20.95 | 33.62 | 8.94 | 6.53 | 2.84 |
|
ROE (%)
|
24.56 | 13.15 | 6.13 | 5.10 | 2.09 |
|
ROA (%)
|
6.57 | 12.03 | 5.18 | 4.15 | -2.55 |
|
EBIT Margin (%)
|
5.79 | 2.98 | 4.89 | 3.09 | -46.02 |
|
Net Margin (%)
|
3.63 | 2.68 | 3.96 | 2.18 | -40.89 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
8.58 | 5.14 | 38.88 | 76.83 | -60.44 |
|
EBIT Growth (%)
|
-3.80 | -62.97 | -13.77 | 181.11 | -159.28 |
|
Net Profit Growth (%)
|
3.76 | -58.35 | -12.13 | 27.00 | -156.63 |
|
EPS Growth (%)
|
3.67 | -95.80 | -44.00 | 27.00 | -152.06 |
|
Book Value Growth (%)
|
-14.87 | 17.78 | 6.21 | 3.69 | 2.11 |
Valuation Ratios
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Price / Earnings
|
27.24 | 12.44 | 14.12 | 12.12 | -47.64 |
|
Price / Book Value
|
6.02 | 1.64 | 1.69 | 0.64 | 1.70 |
|
Dividend Yield (%)
|
1.65 | 6.98 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
16.80 | 6.86 | 21.99 | 8.31 | -99.80 |
|
Market Cap (₹ Cr)
|
10,276.68 | 564.14 | 115.67 | 66.15 | 15.29 |
Solvency Ratios
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.40 | 0.05 | 0.02 | 0.02 | 0.00 |
|
Short term debt to equity ratio
|
0.19 | 0.00 | 0.15 | 0.18 | -- |
|
Current Ratio
|
0.94 | 8.42 | 5.09 | 2.36 | 77.30 |
|
Quick Ratio
|
0.48 | 4.97 | 3.90 | 1.03 | 43.45 |
|
Interest Coverage
|
5.16 | 25.24 | 7.46 | 7.47 | -92.00 |
Operating Efficiency Ratios
| Godrej Agrovet | KSE | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
6.42 | 0.06 | 39.49 | 7.78 | 460.54 |
|
Asset Turnover
|
1.79 | 4.45 | 1.29 | 1.89 | 0.05 |
|
Receivable days
|
21.15 | 0.29 | 126.71 | 34.07 | 561.48 |
|
Inventory Days
|
44.46 | 27.72 | 87.41 | 63.48 | 1,011.41 |
|
Payable days
|
31.76 | 2.46 | 3.90 | 15.31 | 28.80 |
|
Cash Conversion Cycle
|
33.86 | 25.54 | 210.22 | 82.25 | 1,544.08 |